A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...
TriLink BioTechnologies senior scientist Dr Cody Palumbo discusses the blockers to manufacturing mRNA-based gene editing ...
Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief ...
While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...
Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business ...
Moderna is currently in the middle of an aggressive cost-cutting campaign. In September last year, the company announced that ...
Vaccine experts said the memo was irresponsible and omits key details about how officials arrived at the conclusion.
Shares of Moderna, Inc. (NASDAQ:MRNA) are trading lower Monday following reports suggesting tighter controls on how vaccines gain approval.